Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bosentan Dispersible Tablets

Approval Number

国药准字HJ20190051

CompanyJanssen-Cilag AG

Registration Date

June 18, 2024

Previous Approval Numbers

H20190051

Drug Information

Generic Name

波生坦分散片

Trade Name

全可利

Dosage Form

片剂

Strength

32mg(以C₂₇H₂₉N₅O₆S计)

Drug Type

化学药品

Registration Date

June 18, 2024

Expiry Date

June 17, 2029

Company Information

Applicant Company

Company NameJanssen-Cilag AG

Company Address

Gubelstrasse 34,6300 Zug, Switzerland

Manufacturing Company

Company NamePatheon Inc

Company Address

2100 Syntex Court,Mississauga,Ontario,L5N 7K9,Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy